IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 1, 2009
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-2539

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.08-2539v1
50/2/516    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sjo, L. D.
Right arrow Articles by Ralfkiaer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sjo, L. D.
Right arrow Articles by Ralfkiaer, E.

Article

Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical and cytogenetical characteristics

Lene Dissing Sjo 1, Steffen Heegaard 2*, Jan Ulrik Prause 1, Bodil Laub Petersen 3, Sanni Pedersen 3, and Elisabeth Ralfkiaer 3

1 Dept. of Neuroscience and Pharmacology, Eye Pathology Institute, University of Copenhagen, Copenhagen, Denmark
2 University of Copenhagen, Eye Pathology Institute, Frederik V's Vej 11, Copenhagen, DK-2100, Denmark
3 Copenhagen University Hospital, Rigshospitalet, Dept. of Pathology, Copenhagen, Denmark

* To whom correspondence should be addressed. E-mail: sthe{at}sund.ku.dk.


   Abstract

PURPOSE. To evaluate clinical-, immunophenotypical- and cytogenetical characteristics of 116 patients with a diagnosis of extranodal marginal zone lymphoma (EMZL) presenting primarily in the ocular region. METHODS. Specimens from all patients diagnosed with ophthalmic lymphoma in Denmark during the period 1980 to 2005 were reviewed and reclassified according to the WHO classification. Cases reclassified as EMZL were selected and reviewed with respect to clinical characteristics and outcome. The presence of translocations involving IGH and/or MALT1 was investigated in 42 specimens by fluorescence in situ hybridization (FISH). RESULTS. Median age was 69 years. Most lymphomas were located in the orbit. Around one fourth of patients had disseminated disease at presentation. One third of patients had a relapse or progression of disease after initial therapy and relapses were frequently found at extra-ocular sites. Five-year progression free survival and overall survival rates were 71% and 75% respectively. Translocations involving the IGH- or MALT1gene loci were detected in two of 42 specimens (5%). In Cox regression multivariate analysis IGH-translocation was the only factor associated with PFS whereas favorable International Prognostic Index (IPI) score was the most reliable predictor of OS. CONCLUSIONS. EMZL presenting in the ocular region usually runs an indolent course, but relapses are frequently seen. The IPI-score was the most reliable independent parameter for estimating risk of death in our cohort of patients. Furthermore, we found that the frequency of translocations involving the MALT1- and IGH-gene loci is low in ocular region EMZL.

Key Words: immunopathology, in situ hybridization, fluorescent probes







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology